RECOMMENDATIONS.CELIDA.CODEX.NETZWERK-UNIVERSITAETSMEDIZIN.DE\Therapeutic Anticoagulation Plan (hospitalised, non-intensive care, COVID-19 patients with no renal function impairment (eGFR >= 30ml/min)) - TTL Representation

CODEX+ CELIDA Recommendations - Local Development build (v1.5.2) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
: Therapeutic Anticoagulation Plan (hospitalised, non-intensive care, COVID-19 patients with no renal function impairment (eGFR >= 30ml/min)) - TTL Representation

Active as of 2022-02
Raw ttl | Download

@prefix fhir: <http://hl7.org/fhir/> .
@prefix loinc: <https://loinc.org/rdf/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix sct: <http://snomed.info/id/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

 a fhir:PlanDefinition ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "TherapeuticAnticoagulationNonICUHighRiskCOVID19PatientsPlan"] ; # 
  fhir:meta [
    ( fhir:profile [
fhir:v "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/recommendation-plan"^^xsd:anyURI ;
fhir:link <https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/recommendation-plan>     ] )
  ] ; # 
  fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: PlanDefinition TherapeuticAnticoagulationNonICUHighRiskCOVID19PatientsPlan</b></p><a name=\"TherapeuticAnticoagulationNonICUHighRiskCOVID19PatientsPlan\"> </a><a name=\"hcTherapeuticAnticoagulationNonICUHighRiskCOVID19PatientsPlan\"> </a><a name=\"TherapeuticAnticoagulationNonICUHighRiskCOVID19PatientsPlan-en-US\"> </a><p><b>url</b>: <a href=\"PlanDefinition-TherapeuticAnticoagulationNonICUHighRiskCOVID19PatientsPlan.html\">PlanDefinition Therapeutic Anticoagulation Plan (hospitalised, non-intensive care, COVID-19 patients</a></p><p><b>version</b>: 7.0</p><p><b>name</b>: Therapeutic_Anticoagulation_No_Renal_Function_Impairment</p><p><b>title</b>: Therapeutic Anticoagulation Plan (hospitalised, non-intensive care, COVID-19 patients</p><p><b>type</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/plan-definition-type eca-rule}\">ECA Rule</span></p><p><b>status</b>: Active</p><p><b>experimental</b>: true</p><p><b>subject</b>: <a href=\"EvidenceVariable-PopHospitalisedNonICUCOVID19PatientsWITHHighRisk.html\">Population: Hospitalised COVID-19 patients without the need for intensive care therapy considered high-risk for developing venous thrombosis</a></p><p><b>date</b>: 2022-02</p><p><b>publisher</b>: NUM CODEX+ CELIDA</p><p><b>description</b>: </p><div><p>In hospitalized, non-intensive care patients with COVID-19 and increased risk (e.g., D-dimers ≥ 2 mg/l), therapeutic anticoagulation can be considered if the risk of bleeding is low. Anticoagulation, preferentially with NMH or UFH, can be considered.</p>\n</div><blockquote><p><b>goal</b></p><blockquote><p><b>id</b></p>aPTT-goal</blockquote><p><b>category</b>: <span title=\"Codes:{http://snomed.info/sct 410394004}\">Lab findings surveillance (regime/therapy)</span></p><p><b>description</b>: <span title=\"Codes:\">aPTT value should be &gt; 50 sec.</span></p><h3>Targets</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Measure</b></td><td><b>Detail[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://loinc.org 3173-2}\">aPTT in Blood by Coagulation assay</span></td><td>50.0000001-? sec</td></tr></table></blockquote><blockquote><p><b>action</b></p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 432102000}\">Administration of substance (procedure)</span></p><p><b>goalId</b>: aPTT-goal</p><p><b>definition</b>: <a href=\"ActivityDefinition-TherapeuticAnticoagulationUFH.html\">Therapeutic Anticoagulation Treatment UFH</a></p></blockquote><blockquote><p><b>action</b></p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 432102000}\">Administration of substance (procedure)</span></p><p><b>definition</b>: <a href=\"ActivityDefinition-TherapeuticAnticoagulationNMHDalteparin1xd.html\">Therapeutic Anticoagulation Treatment with Dalteparin</a></p></blockquote><blockquote><p><b>action</b></p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 432102000}\">Administration of substance (procedure)</span></p><p><b>definition</b>: <a href=\"ActivityDefinition-TherapeuticAnticoagulationNMHDalteparin2xd.html\">Therapeutic Anticoagulation Treatment with Dalteparin</a></p></blockquote><blockquote><p><b>action</b></p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 432102000}\">Administration of substance (procedure)</span></p><p><b>definition</b>: <a href=\"ActivityDefinition-TherapeuticAnticoagulationNMHDalteparinTable.html\">Therapeutic Anticoagulation Treatment with Dalteparin</a></p></blockquote><blockquote><p><b>action</b></p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 432102000}\">Administration of substance (procedure)</span></p><p><b>definition</b>: <a href=\"ActivityDefinition-TherapeuticAnticoagulationNMHNadroparin.html\">Therapeutic Anticoagulation Treatment with Nadroparin</a></p></blockquote><blockquote><p><b>action</b></p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 432102000}\">Administration of substance (procedure)</span></p><p><b>definition</b>: <a href=\"ActivityDefinition-TherapeuticAnticoagulationNMHEnoxaparin1xd.html\">Therapeutic Anticoagulation Treatment with Enoxaparin</a></p></blockquote><blockquote><p><b>action</b></p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 432102000}\">Administration of substance (procedure)</span></p><p><b>definition</b>: <a href=\"ActivityDefinition-TherapeuticAnticoagulationNMHEnoxaparin2xd.html\">Therapeutic Anticoagulation Treatment with Enoxaparin</a></p></blockquote><blockquote><p><b>action</b></p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 432102000}\">Administration of substance (procedure)</span></p><p><b>definition</b>: <a href=\"ActivityDefinition-TherapeuticAnticoagulationNMHCertoparin.html\">Therapeutic Anticoagulation Treatment with Certoparin</a></p></blockquote><blockquote><p><b>action</b></p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 432102000}\">Administration of substance (procedure)</span></p><p><b>definition</b>: <a href=\"ActivityDefinition-TherapeuticAnticoagulationFondaparinux.html\">Therapeutic Anticoagulation Treatment with Fondaparinux</a></p></blockquote><blockquote><p><b>action</b></p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 432102000}\">Administration of substance (procedure)</span></p><p><b>goalId</b>: aPTT-goal</p><p><b>definition</b>: <a href=\"ActivityDefinition-TherapeuticAnticoagulationWArgatra.html\">Therapeutic Anticoagulation Treatment with Argatroban</a></p></blockquote><blockquote><p><b>action</b></p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 432102000}\">Administration of substance (procedure)</span></p><p><b>definition</b>: <a href=\"ActivityDefinition-TherapeuticAnticoagulationNMHTinzaparin.html\">Therapeutic Anticoagulation Treatment with Tinzaparin</a></p></blockquote></div>"
  ] ; # 
  fhir:extension ( [
fhir:url [ fhir:v "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability"^^xsd:anyURI ] ;
fhir:value [ fhir:v "computable" ]
  ] [
fhir:url [ fhir:v "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeRepresentationLevel"^^xsd:anyURI ] ;
fhir:value [ fhir:v "structured" ]
  ] [
fhir:url [ fhir:v "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-partOf"^^xsd:anyURI ] ;
fhir:value [
fhir:v "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommendation/therapeutic-anticoagulation"^^xsd:anyURI ;
fhir:link <https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommendation/therapeutic-anticoagulation>     ]
  ] [
    ( fhir:extension [
fhir:url [ fhir:v "method"^^xsd:anyURI ] ;
fhir:value [
a fhir:CodeableConcept ;
        ( fhir:coding [
fhir:system [ fhir:v "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/cs-action-combination-method"^^xsd:anyURI ] ;
fhir:code [ fhir:v "at-least" ]         ] )       ]     ] [
fhir:url [ fhir:v "threshold"^^xsd:anyURI ] ;
fhir:value [ fhir:v "1"^^xsd:positiveInteger ]     ] ) ;
fhir:url [ fhir:v "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/ext-action-combination-method"^^xsd:anyURI ]
  ] ) ; # 
  fhir:url [ fhir:v "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/intervention-plan/therapeutic-anticoagulation"^^xsd:anyURI] ; # 
  fhir:version [ fhir:v "7.0"] ; # 
  fhir:name [ fhir:v "Therapeutic_Anticoagulation_No_Renal_Function_Impairment"] ; # 
  fhir:title [ fhir:v "Therapeutic Anticoagulation Plan (hospitalised, non-intensive care, COVID-19 patients"] ; # 
  fhir:type [
    ( fhir:coding [
fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/plan-definition-type"^^xsd:anyURI ] ;
fhir:code [ fhir:v "eca-rule" ]     ] )
  ] ; # 
  fhir:status [ fhir:v "active"] ; # 
  fhir:experimental [ fhir:v "true"^^xsd:boolean] ; # 
  fhir:subject [
fhir:v "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/population/hospitalised-non-icu-covid19-patients-high-risk"^^xsd:anyURI ;
fhir:link <https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/population/hospitalised-non-icu-covid19-patients-high-risk>
  ] ; # 
  fhir:date [ fhir:v "2022-02"^^xsd:gYearMonth] ; # 
  fhir:publisher [ fhir:v "NUM CODEX+ CELIDA"] ; # 
  fhir:description [ fhir:v "In hospitalized, non-intensive care patients with COVID-19 and increased risk (e.g., D-dimers ≥ 2 mg/l), therapeutic anticoagulation can be considered if the risk of bleeding is low. Anticoagulation, preferentially with NMH or UFH, can be considered."] ; # 
  fhir:goal ( [
fhir:id [ fhir:v "aPTT-goal" ] ;
fhir:category [
      ( fhir:coding [
a sct:410394004 ;
fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ;
fhir:code [ fhir:v "410394004" ] ;
fhir:display [ fhir:v "Lab findings surveillance (regime/therapy)" ]       ] )     ] ;
fhir:description [
fhir:text [ fhir:v "aPTT value should be > 50 sec." ]     ] ;
    ( fhir:target [
fhir:measure [
        ( fhir:coding [
a loinc:3173-2 ;
fhir:system [ fhir:v "http://loinc.org"^^xsd:anyURI ] ;
fhir:code [ fhir:v "3173-2" ] ;
fhir:display [ fhir:v "aPTT in Blood by Coagulation assay" ]         ] )       ] ;
fhir:detail [
a fhir:Range ;
fhir:low [
fhir:value [ fhir:v "50.0000001"^^xsd:decimal ] ;
fhir:unit [ fhir:v "sec" ] ;
fhir:system [ fhir:v "http://unitsofmeasure.org"^^xsd:anyURI ] ;
fhir:code [ fhir:v "s" ]         ]       ]     ] )
  ] ) ; # 
  fhir:action ( [
fhir:code [
      ( fhir:coding [
a sct:432102000 ;
fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ;
fhir:code [ fhir:v "432102000" ] ;
fhir:display [ fhir:v "Administration of substance (procedure)" ]       ] )     ] ;
    ( fhir:goalId [ fhir:v "aPTT-goal" ] ) ;
fhir:definition [
fhir:v "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-UFH-administration"^^xsd:anyURI ;
fhir:link <https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-UFH-administration>     ]
  ] [
fhir:code [
      ( fhir:coding [
a sct:432102000 ;
fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ;
fhir:code [ fhir:v "432102000" ] ;
fhir:display [ fhir:v "Administration of substance (procedure)" ]       ] )     ] ;
fhir:definition [
fhir:v "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-dalteparin-administration-1xd"^^xsd:anyURI ;
fhir:link <https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-dalteparin-administration-1xd>     ]
  ] [
fhir:code [
      ( fhir:coding [
a sct:432102000 ;
fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ;
fhir:code [ fhir:v "432102000" ] ;
fhir:display [ fhir:v "Administration of substance (procedure)" ]       ] )     ] ;
fhir:definition [
fhir:v "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-dalteparin-administration-2xd"^^xsd:anyURI ;
fhir:link <https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-dalteparin-administration-2xd>     ]
  ] [
fhir:code [
      ( fhir:coding [
a sct:432102000 ;
fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ;
fhir:code [ fhir:v "432102000" ] ;
fhir:display [ fhir:v "Administration of substance (procedure)" ]       ] )     ] ;
fhir:definition [
fhir:v "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-dalteparin-administration-table"^^xsd:anyURI ;
fhir:link <https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-dalteparin-administration-table>     ]
  ] [
fhir:code [
      ( fhir:coding [
a sct:432102000 ;
fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ;
fhir:code [ fhir:v "432102000" ] ;
fhir:display [ fhir:v "Administration of substance (procedure)" ]       ] )     ] ;
fhir:definition [
fhir:v "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-nadroparin-administration"^^xsd:anyURI ;
fhir:link <https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-nadroparin-administration>     ]
  ] [
fhir:code [
      ( fhir:coding [
a sct:432102000 ;
fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ;
fhir:code [ fhir:v "432102000" ] ;
fhir:display [ fhir:v "Administration of substance (procedure)" ]       ] )     ] ;
fhir:definition [
fhir:v "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-enoxaparin-administration-1xd"^^xsd:anyURI ;
fhir:link <https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-enoxaparin-administration-1xd>     ]
  ] [
fhir:code [
      ( fhir:coding [
a sct:432102000 ;
fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ;
fhir:code [ fhir:v "432102000" ] ;
fhir:display [ fhir:v "Administration of substance (procedure)" ]       ] )     ] ;
fhir:definition [
fhir:v "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-enoxaparin-administration-2xd"^^xsd:anyURI ;
fhir:link <https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-enoxaparin-administration-2xd>     ]
  ] [
fhir:code [
      ( fhir:coding [
a sct:432102000 ;
fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ;
fhir:code [ fhir:v "432102000" ] ;
fhir:display [ fhir:v "Administration of substance (procedure)" ]       ] )     ] ;
fhir:definition [
fhir:v "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-certoparin-administration"^^xsd:anyURI ;
fhir:link <https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-certoparin-administration>     ]
  ] [
fhir:code [
      ( fhir:coding [
a sct:432102000 ;
fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ;
fhir:code [ fhir:v "432102000" ] ;
fhir:display [ fhir:v "Administration of substance (procedure)" ]       ] )     ] ;
fhir:definition [
fhir:v "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-fondaparinux-administration"^^xsd:anyURI ;
fhir:link <https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-fondaparinux-administration>     ]
  ] [
fhir:code [
      ( fhir:coding [
a sct:432102000 ;
fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ;
fhir:code [ fhir:v "432102000" ] ;
fhir:display [ fhir:v "Administration of substance (procedure)" ]       ] )     ] ;
    ( fhir:goalId [ fhir:v "aPTT-goal" ] ) ;
fhir:definition [
fhir:v "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-argatroban-administration"^^xsd:anyURI ;
fhir:link <https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-argatroban-administration>     ]
  ] [
fhir:code [
      ( fhir:coding [
a sct:432102000 ;
fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ;
fhir:code [ fhir:v "432102000" ] ;
fhir:display [ fhir:v "Administration of substance (procedure)" ]       ] )     ] ;
fhir:definition [
fhir:v "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-tinzaparin-administration"^^xsd:anyURI ;
fhir:link <https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-tinzaparin-administration>     ]
  ] ) . #